bone metastases;
renal carcinoma;
urothelial carcinoma;
prostatic carcinoma;
D O I:
10.1007/s00120-007-1519-y
中图分类号:
R5 [内科学];
R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号:
1002 ;
100201 ;
摘要:
The skeletal system is the most frequent metastatic site of hematogenous spread of urologic carcinomas. Osseus metastases are classified as osteoneutral, osteolytic, osteoblastic and combinations thereof. Osteolytic metastases lead to bone resorption by activating osteoclasts, while osteoblastic metastases stimulate osteoblasts by paracrine mechanisms. The local osteoblastic effect is associated with secondary systemic bone resorption. The use of bisphosphonates is now an established supportive therapy and newer treatment strategies including targeted intervention in the pathophysiology of bone metastases and radioimmunotherapy are being applied or will be coming soon.
机构:
UFR Med Lyon Est Domaine Laennec, INSERM, UMR1033, F-69372 Lyon 08, France
Univ Lyon, F-69008 Lyon, France
LabEx DEVweCAN, F-69372 Lyon, FranceUFR Med Lyon Est Domaine Laennec, INSERM, UMR1033, F-69372 Lyon 08, France
机构:WHO Collaborating Centre for Metabolic Bone Diseases, Department of Human Metabolism and Clinical Biochemistry, University of Sheffield Medical School, Sheffield